NORTHWEST BIOTHERAPEUTICS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Northwest Biotherapeutics Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Northwest Biotherapeutics Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$14.8M, a 7.06% decline year-over-year.
  • Northwest Biotherapeutics Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.2M, a 7.87% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2023 was -$55.5M, a 17.4% increase from 2022.
  • Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2022 was -$67.2M, a 27.5% decline from 2021.
  • Northwest Biotherapeutics Inc annual Operating Income (Loss) for 2021 was -$52.7M, a 39.1% increase from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$63.2M -$14.8M -$976K -7.06% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 -$62.2M -$17.5M -$3.89M -28.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 -$58.3M -$15.7M -$2.78M -21.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$55.5M -$15.1M +$3.04M +16.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 -$58.5M -$13.8M +$1.79M +11.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 -$60.3M -$13.6M +$7.52M +35.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$67.9M -$13M -$678K -5.52% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$67.2M -$18.2M -$7.5M -70.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 -$59.7M -$15.6M -$5.57M -55.4% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$54.1M -$21.1M -$8.69M -70.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 -$45.4M -$12.3M +$7.28M +37.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 -$52.7M -$10.7M +$12.7M +54.3% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-05
Q3 2021 -$65.4M -$10M +$37.8M +79% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$103M -$12.4M -$4.87M -64.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$98.3M -$19.6M -$11.7M -150% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q4 2020 -$86.6M -$23.4M -$16.4M -234% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-28
Q3 2020 -$70.2M -$47.9M -$41.3M -627% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$28.9M -$7.54M -$899K -13.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$28M -$7.83M -$67K -0.86% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$28M -$6.99M -$4M -134% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-01
Q3 2019 -$24M -$6.59M +$2.73M +29.3% Jul 1, 2019 Sep 30, 2019 10-Q 2021-01-15
Q2 2019 -$26.7M -$6.64M +$13.7M +67.4% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 -$40.4M -$7.77M +$1.05M +11.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-06-24
Q4 2018 -$41.5M -$2.99M +$15M +83.4% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-16
Q3 2018 -$56.5M -$9.32M +$4.81M +34.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 -$61.3M -$20.4M -$9.69M -90.8% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$51.6M -$8.82M +$3.09M +25.9% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$54.7M -$18M +$3.27M +15.4% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-02
Q3 2017 -$58M -$14.1M +$11.4M +44.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-16
Q2 2017 -$69.3M -$10.7M +$4.36M +29% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$73.7M -$11.9M +$5.58M +31.9% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-16
Q4 2016 -$79.3M -$21.2M +$30.1M +58.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-04-17
Q3 2016 -$109M -$25.5M -$12.3M -93.1% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-20
Q2 2016 -$97.1M -$15M +$23.8M +61.3% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$121M -$17.5M +$5.35M +23.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$126M -$51.4M -$26M -102% Oct 1, 2015 Dec 31, 2015 10-K 2017-04-17
Q3 2015 -$100M -$13.2M +$13.4M +50.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 -$114M -$38.9M -$13.4M -52.8% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$100M -$22.8M +$851K +3.59% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-11
Q4 2014 -$101M -$25.4M -$10.8M -73.3% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-16
Q3 2014 -$90.4M -$26.6M -$11.2M -72.2% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 -$79.2M -$25.4M -$14M -123% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$65.2M -$23.7M -$9.74M -69.8% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q4 2013 -$55.5M -$14.7M +$911K +5.85% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-16
Q3 2013 -$56.4M -$15.5M -$1.71M -12.5% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-19
Q2 2013 -$54.7M -$11.4M -$2.67M -30.5% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-15
Q1 2013 -$52M -$13.9M -$8.18M -142% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
Q4 2012 -$43.8M -$15.6M -$10.9M -236% Oct 1, 2012 Dec 31, 2012 10-K 2014-04-01
Q3 2012 -$32.9M -$13.7M -$7.38M -116% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-15
Q2 2012 -$25.5M -$8.74M +$291K +3.22% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$25.8M -$5.77M +$991K +14.7% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$26.8M -$4.64M Oct 1, 2011 Dec 31, 2011 10-K 2013-04-08
Q3 2011 -$6.36M -$3.35M -111% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-14
Q2 2011 -$9.03M -$5.92M -191% Apr 1, 2011 Jun 30, 2011 10-Q/A 2012-09-12
Q1 2011 -$6.76M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-21
Q3 2010 -$3.01M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$3.11M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.